Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats

K. Nakao, A. Sugawara, S. Shiono, Y. Saito, N. Morii, T. Yamada, Hiroshi Itoh, M. Mukoyama, H. Arai, M. Sakamoto, H. Imura

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

To elucidate the secretory form of atrial natriuretic polypeptide from the atrium, the molecular form of atrial natriuretic polypeptide in the perfusate from the isolated beating rat heart and in plasma taken at the coronary sinus of 10 patients during cardiac catheterization has been investigated using high performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for atrial natriuretic polypeptide. Atrial natriuretic polypeptide in the perfusate from the rat heart showed a single peak eluting at the position of a low molecular weight form of atrial natriuretic polypeptide, without any detectable amounts of atrial natriuretic polypeptide with high molecular weights. The major component of atrial natriuretic polypeptide in the rat heart perfusate co-migrated with rat α-atrial natriuretic polypeptide in reverse phase high performance liquid chromatography. In 9 out of 10 patients atrial natriuretic polypeptide in plasma taken at the coronary sinus revealed a single peak of atrial natriuretic polypeptide emerging at the position of human α-atrial natriuretic polypeptide in gel filtration. Only one plasma sample had a small quantity of high molecular weight forms with the predominant low molecular weight form of atrial natriuretic polypeptide. The major component of atrial natriuretic polypeptide in the plasma extract from the coronary sinus was identified with human α-atrial natriuretic polypeptide. These results indicate that α-ANP, a 28-amino acid polypeptide, is secreted as a cardiac hormone into the coronary blood stream from the atrium.

Original languageEnglish
Pages (from-to)1756-1761
Number of pages6
JournalCanadian Journal of Physiology and Pharmacology
Volume65
Issue number8
Publication statusPublished - 1987
Externally publishedYes

Fingerprint

Hormones
Peptides
Coronary Sinus
Molecular Weight
Reverse-Phase Chromatography
Gel Chromatography
High Pressure Liquid Chromatography
Atrial Natriuretic Factor
Cardiac Catheterization
Radioimmunoassay
Amino Acids

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

Nakao, K., Sugawara, A., Shiono, S., Saito, Y., Morii, N., Yamada, T., ... Imura, H. (1987). Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats. Canadian Journal of Physiology and Pharmacology, 65(8), 1756-1761.

Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats. / Nakao, K.; Sugawara, A.; Shiono, S.; Saito, Y.; Morii, N.; Yamada, T.; Itoh, Hiroshi; Mukoyama, M.; Arai, H.; Sakamoto, M.; Imura, H.

In: Canadian Journal of Physiology and Pharmacology, Vol. 65, No. 8, 1987, p. 1756-1761.

Research output: Contribution to journalArticle

Nakao, K, Sugawara, A, Shiono, S, Saito, Y, Morii, N, Yamada, T, Itoh, H, Mukoyama, M, Arai, H, Sakamoto, M & Imura, H 1987, 'Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats', Canadian Journal of Physiology and Pharmacology, vol. 65, no. 8, pp. 1756-1761.
Nakao K, Sugawara A, Shiono S, Saito Y, Morii N, Yamada T et al. Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats. Canadian Journal of Physiology and Pharmacology. 1987;65(8):1756-1761.
Nakao, K. ; Sugawara, A. ; Shiono, S. ; Saito, Y. ; Morii, N. ; Yamada, T. ; Itoh, Hiroshi ; Mukoyama, M. ; Arai, H. ; Sakamoto, M. ; Imura, H. / Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats. In: Canadian Journal of Physiology and Pharmacology. 1987 ; Vol. 65, No. 8. pp. 1756-1761.
@article{07adf53b225144a6bcb4a079280cd896,
title = "Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats",
abstract = "To elucidate the secretory form of atrial natriuretic polypeptide from the atrium, the molecular form of atrial natriuretic polypeptide in the perfusate from the isolated beating rat heart and in plasma taken at the coronary sinus of 10 patients during cardiac catheterization has been investigated using high performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for atrial natriuretic polypeptide. Atrial natriuretic polypeptide in the perfusate from the rat heart showed a single peak eluting at the position of a low molecular weight form of atrial natriuretic polypeptide, without any detectable amounts of atrial natriuretic polypeptide with high molecular weights. The major component of atrial natriuretic polypeptide in the rat heart perfusate co-migrated with rat α-atrial natriuretic polypeptide in reverse phase high performance liquid chromatography. In 9 out of 10 patients atrial natriuretic polypeptide in plasma taken at the coronary sinus revealed a single peak of atrial natriuretic polypeptide emerging at the position of human α-atrial natriuretic polypeptide in gel filtration. Only one plasma sample had a small quantity of high molecular weight forms with the predominant low molecular weight form of atrial natriuretic polypeptide. The major component of atrial natriuretic polypeptide in the plasma extract from the coronary sinus was identified with human α-atrial natriuretic polypeptide. These results indicate that α-ANP, a 28-amino acid polypeptide, is secreted as a cardiac hormone into the coronary blood stream from the atrium.",
author = "K. Nakao and A. Sugawara and S. Shiono and Y. Saito and N. Morii and T. Yamada and Hiroshi Itoh and M. Mukoyama and H. Arai and M. Sakamoto and H. Imura",
year = "1987",
language = "English",
volume = "65",
pages = "1756--1761",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "8",

}

TY - JOUR

T1 - Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats

AU - Nakao, K.

AU - Sugawara, A.

AU - Shiono, S.

AU - Saito, Y.

AU - Morii, N.

AU - Yamada, T.

AU - Itoh, Hiroshi

AU - Mukoyama, M.

AU - Arai, H.

AU - Sakamoto, M.

AU - Imura, H.

PY - 1987

Y1 - 1987

N2 - To elucidate the secretory form of atrial natriuretic polypeptide from the atrium, the molecular form of atrial natriuretic polypeptide in the perfusate from the isolated beating rat heart and in plasma taken at the coronary sinus of 10 patients during cardiac catheterization has been investigated using high performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for atrial natriuretic polypeptide. Atrial natriuretic polypeptide in the perfusate from the rat heart showed a single peak eluting at the position of a low molecular weight form of atrial natriuretic polypeptide, without any detectable amounts of atrial natriuretic polypeptide with high molecular weights. The major component of atrial natriuretic polypeptide in the rat heart perfusate co-migrated with rat α-atrial natriuretic polypeptide in reverse phase high performance liquid chromatography. In 9 out of 10 patients atrial natriuretic polypeptide in plasma taken at the coronary sinus revealed a single peak of atrial natriuretic polypeptide emerging at the position of human α-atrial natriuretic polypeptide in gel filtration. Only one plasma sample had a small quantity of high molecular weight forms with the predominant low molecular weight form of atrial natriuretic polypeptide. The major component of atrial natriuretic polypeptide in the plasma extract from the coronary sinus was identified with human α-atrial natriuretic polypeptide. These results indicate that α-ANP, a 28-amino acid polypeptide, is secreted as a cardiac hormone into the coronary blood stream from the atrium.

AB - To elucidate the secretory form of atrial natriuretic polypeptide from the atrium, the molecular form of atrial natriuretic polypeptide in the perfusate from the isolated beating rat heart and in plasma taken at the coronary sinus of 10 patients during cardiac catheterization has been investigated using high performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for atrial natriuretic polypeptide. Atrial natriuretic polypeptide in the perfusate from the rat heart showed a single peak eluting at the position of a low molecular weight form of atrial natriuretic polypeptide, without any detectable amounts of atrial natriuretic polypeptide with high molecular weights. The major component of atrial natriuretic polypeptide in the rat heart perfusate co-migrated with rat α-atrial natriuretic polypeptide in reverse phase high performance liquid chromatography. In 9 out of 10 patients atrial natriuretic polypeptide in plasma taken at the coronary sinus revealed a single peak of atrial natriuretic polypeptide emerging at the position of human α-atrial natriuretic polypeptide in gel filtration. Only one plasma sample had a small quantity of high molecular weight forms with the predominant low molecular weight form of atrial natriuretic polypeptide. The major component of atrial natriuretic polypeptide in the plasma extract from the coronary sinus was identified with human α-atrial natriuretic polypeptide. These results indicate that α-ANP, a 28-amino acid polypeptide, is secreted as a cardiac hormone into the coronary blood stream from the atrium.

UR - http://www.scopus.com/inward/record.url?scp=0023606679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023606679&partnerID=8YFLogxK

M3 - Article

C2 - 2961427

AN - SCOPUS:0023606679

VL - 65

SP - 1756

EP - 1761

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 8

ER -